Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSupply@me Cap Regulatory News (SYME)

  • This share is currently suspended. It was suspended at a price of 0.0026

Share Price Information for Supply@me Cap (SYME)

Share Price is delayed by 15 minutes
Get Live Data
0.0026    0.00 (0.00%)
Bid:
0.00
Ask:
0.00
Spread: 0.00 (0.00%)
Market Cap: £1.87m
SYME Live PriceLast checked at - London Stock Exchange

Intraday Supply@me Cap Share Chart

New £7million Loan Note Facility completed

29 Sep 2021 07:00

RNS Number : 3010N
Supply @ME Capital PLC
29 September 2021
 

THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION AS STIPULATED UNDER THE UK VERSION OF THE MARKET ABUSE REGULATION NO 596/2014 WHICH IS PART OF ENGLISH LAW BY VIRTUE OF THE EUROPEAN UNION (WITHDRAWAL) ACT 2018, AS AMENDED. ON PUBLICATION OF THIS ANNOUNCEMENT VIA A REGULATORY INFORMATION SERVICE, THIS INFORMATION IS CONSIDERED TO BE IN THE PUBLIC DOMAIN.

 

29 September 2021

 

Supply@ME Capital plc

(The "Company" or "SYME")

New £7 million Loan Note Facility completed

Supply@ME finalises short-term loan facility with Mercator Capital Management Fund LP to close Agreement with Negma Group

 

Supply@ME Capital plc, the fintech business which provides an innovative Platform for use by manufacturing and trading companies to access Inventory Monetisation© solutions enabling their businesses to generate cashflow, is pleased to announce that further to the agreement of term sheets, as per the RNS of 2 September 2021, it has now finalised and signed a short-term loan facility with Mercator Capital Management Fund LP ("Mercator").

Mercator is a Cayman regulated fund, introduced to the Company by ARC Group ("ARC"), a global Investment Bank specialising in the middle markets, with representative offices across all continents. ARC focuses on providing global fundraising solutions to its clients from institutional investors.

The short-term loan facility replaces the Subscription Agreement previously signed with Negma Group Ltd ("Negma Group"), as set out in the RNS of 16 June 2021. Following the most recent issuance of 840,000,000 New Ordinary Shares which were allotted to Negma Group as per the RNS of 2 September 2021, the remaining outstanding par value of the Convertible Loan Notes not yet converted of £2,016,000 is expected to be repaid in cash by the Company, funded by the new short-term loan facility.

SYME will also use the funds to support the Group's growth and its ongoing working capital requirements. SYME will also continue to work closely with ARC to further explore its NASDAQ dual listing' project.

 

Alessandro Zamboni, CEO, Supply@ME Capital plc, said: "We are delighted to finalise our agreement with Mercator Capital Management Fund. The funds will increase our balance sheet flexibility and ensure we are well funded as we continue our business expansion. We are hugely grateful to ARC for introducing us to a high-quality funding partner".

 

Detail of the Loan arrangement

SYME has agreed to the following key terms for the short-term loan note facility:

· Initial draw down of £5 million, with a further £2 million available within 60 days subject to certain conditions precedent;

· 12 month term, with an interest rate of 10%; and

· Warrants will be issued representing 20% of both tranches. The warrants will have a term of 3 years from issue and an exercise price of 130% of the lowest closing VWAP over the ten trading days immediately preceding the issue of the warrants.

The short-term loan note facility will be linked to a Convertible Loan Note facility (CLN), which can be used should SYME elect not to repay any of the interest or principal relating to the short-term loan notes in cash (for example, if the Company decides to preserve cash for working capital requirements or to facilitate further new strategic initiatives). The CLN facility is for the same aggregate value as the short-term loan facility including interest (£7.7 million) and can be drawn in tranches equal to the monthly loan repayments. The CLN contains the following key terms:

· Issued at par value;

· 12 month term with a conversion price of 85% of the lowest 10 day closing VWAP prior to the issue of the conversion notice. Mercator can convert CLNs on request once issued. The Company can elect to repay in cash any CLNs which are not subject to any conversion requests at 105% of the outstanding nominal value;

· Any CLNs outstanding on the first anniversary of issue will automatically convert into Ordinary Shares; and

· Warrants will be issued for 20% of each tranche. The warrants will have a term of 3 years from issue and an exercise price of 130% of the lowest closing VWAP over the ten trading days immediately preceding the request to issue a new tranche.

The Company has given Mercator customary warranties in respect of certain commercial matters. The Company has also agreed not to undertake certain matters without the Investor's consent (not to be unreasonably withheld, delayed or condition), including undertaking further indebtedness, charging its assets and issuing shares (subject to certain exemptions, including share issues to employees, directors and their related parties).

Notes

Supply@ME Capital PLC and its operating subsidiaries (together the "Group") provide an innovative fintech platform (the "Platform") for use by manufacturing and trading companies to access inventory trade solutions enabling their businesses to generate cashflow, via a non-credit approach and without incurring debt. This is achieved by their existing eligible inventory being added to the Platform and then monetised via purchase by third party Inventory Funders. The inventory to be monetised can include warehouse goods waiting to be sold to end-customers or goods/commodities that are part of a typical import/export transaction. SYME announced in August 2021 the launch of the Global Inventory Monetisation Fund ("Fund") which will be focused on both inventory in transit monetisation and warehouse goods monetisation. This Fund will be focused on creditworthy companies and not those in distress or otherwise seeking to monetise illiquid inventories.

Contacts

Alessandro Zamboni, CEO, Supply@ME Capital plc, investors@supplymecapital.com

Paul Vann, Walbrook PR Limited, +44 (0)20 7933 8780; paul.vann@walbrookpr.com

Brian Norris, Cicero/AMO, +44 (0)20 7947 5317 brian.norris@cicero-group.com

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCLPMTTMTATTMB
Date   Source Headline
28th Apr 20267:00 amRNSExercise of Open Offer Warrants
27th Apr 20267:00 amRNSDelay in publishing 2025 Annual Financial Report
10th Apr 20267:00 amRNSExercise of Open Offer Warrants
16th Jan 20267:00 amRNSExercise of Open Offer Warrants
6th Jan 20267:00 amRNSProposed acquisition - Heads of Terms
19th Dec 20257:00 amRNSExercise of Open Offer Warrants
19th Dec 20257:00 amRNSExercise of Open Offer Warrants
5th Dec 202511:05 amRNSResults of AGM and Directorate Change
19th Nov 20257:00 amRNSBusiness update
6th Nov 20257:00 amRNSNotice of AGM
23rd Oct 20258:08 amRNSRestoration of Listing and Trading
23rd Oct 20257:30 amRNSRestoration - Supply@Me Capital plc
20th Oct 20257:00 amRNSFunding update
14th Oct 20257:00 amRNSH1 2025 unaudited interim report and accounts
13th Oct 20257:00 amRNS2024 Annual Report and Accounts
29th Sep 20257:00 amRNSDelay in publication of the H12025 interim results
18th Sep 20257:00 amRNSFunding update
15th Sep 20252:32 pmRNSFunding update
1st Sep 20257:00 amRNSFacility Amendment and Funding Update
31st Jul 20257:00 amRNSFunding update
16th Jul 20257:00 amRNSFunding update
2nd Jul 202512:00 pmRNSFunding update
24th Jun 20257:00 amRNSFunding update
11th Jun 20257:00 amRNSFacility Amendment and Funding Update
2nd Jun 20257:00 amRNSFunding Update
6th May 20257:00 amRNSPDMR Resignation
1st May 20257:00 amRNSFunding update
28th Apr 20257:00 amRNSDelay in published 2024 Annual Report and Accounts
1st Apr 202510:58 amRNSFunding update
19th Mar 20257:00 amRNSNew Funding Facility
14th Feb 20257:00 amRNSAppointment of new auditor
10th Feb 20257:00 amRNSFunding update
20th Jan 20257:00 amRNSDirector’s Other External Appointments
17th Dec 20247:00 amRNSBusiness Update
30th Sep 20242:45 pmRNSUnaudited interim results
25th Sep 20247:00 amRNSResignation of Auditor
6th Sep 20247:00 amRNSDirectorate Change
9th Jul 20247:00 amRNSExercise of Open Offer Warrants
28th Jun 20249:22 amRNSResult of AGM
31st May 202411:14 amRNSHolding(s) in Company
31st May 20247:00 amRNSTotal Voting Rights
29th May 20244:58 pmRNSNotice of Annual General Meeting
21st May 20247:00 amRNSStrategic alliance with p-Chip Corporation
15th May 20247:00 amRNSNew equity funding secured for £1,552,500
10th May 202411:47 amRNSPublication of the 2023 Annual Report and Accounts
9th May 20245:02 pmRNSIndependent Auditor's Report
1st May 20247:00 amRNS2023 Annual Report and Accounts
29th Apr 202412:27 pmRNSAgreement signed to launch a IM programme
5th Apr 20247:00 amRNSBusiness update
4th Apr 20247:00 amRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.